Psoriasis is a chronic immune-mediated inflammatory disease associated with heightened cardiovascular risk. Platelets are increasingly implicated in this link through their capacity to amplify vascular inflammation and interact with leukocytes. Circulating leukocyte–platelet aggregates are elevated in psoriasis, although the biological significance of these aggregates remains incompletely understood. We investigated whether increased leukocyte–platelet aggregates is associated with alterations in the platelet transcriptomic profile in psoriasis.
Methods
Leukocyte–platelet aggregate levels were compared between psoriasis patients (n = 42) and healthy controls (n = 29). Psoriasis patients were stratified by the cohort median lymphocyte-platelet aggregate (LyPA) or neutrophil-platelet aggregate (NPA) levels into high vs low aggregate groups. Platelet RNA sequencing was then performed to define transcriptomic differences in high-vs low-aggregate psoriasis.
Results
Psoriasis patients (mean age 46; 60% male; 81% Caucasian) had higher LyPA (P = 0.001) and NPA (P = 0.04) compared with healthy controls (mean age 42; 55% male; 69% Caucasian). Platelet RNA sequencing revealed that psoriasis patients with high LyPA or high NPA had downregulation of platelet inflammatory pathways, including interferon, tumor necrosis factor (TNF), IL-8, and IL-6 signaling.
Conclusion
These findings identify inflammatory platelet transcriptomic alterations associated with elevated lymphocyte-platelet and neutrophil-platelet aggregates in psoriasis and motivate further work to define the functional consequences of leukocyte-platelet aggregates in psoriasis.
GelfandJMNeimannALShinDBWangXMargolisDJTroxelAB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735-1741. doi:10.1001/jama.296.14.1735.
2.
LiuLCuiSLiuMHuoXZhangGWangN. Psoriasis increased the risk of adverse cardiovascular outcomes: a new systematic review and meta-analysis of cohort study. Front Cardiovasc Med. 2022;9:829709. doi:10.3389/fcvm.2022.829709.
3.
OgdieAYuYHaynesK, et al.Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis. 2015;74(2):326-332. doi:10.1136/annrheumdis-2014-205675.
4.
GarshickMSWardNLKruegerJGBergerJS. Cardiovascular risk in patients with psoriasis: JACC review topic of the week. J Am Coll Cardiol. 2021;77(13):1670-1680. doi:10.1016/j.jacc.2021.02.009.
5.
MehtaNNTeagueHLSwindellWR, et al.IFN-γ and TNF-α synergism may provide a link between psoriasis and inflammatory atherogenesis. Sci Rep. 2017;7(1):13831. doi:10.1038/s41598-017-14365-1.
6.
MartinDATowneJEKricorianG, et al.The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Invest Dermatol. 2013;133(1):17-26. doi:10.1038/jid.2012.194.
7.
KarbachSCroxfordALOelzeM, et al.Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease. Arterioscler Thromb Vasc Biol. 2014;34(12):2658-2668. doi:10.1161/ATVBAHA.114.304108.
8.
GarshickMSDrenkovaKKazatskerF, et al.Platelet activation and a platelet biosignature are associated with cardiovascular risk in patients with controlled psoriasis. Arterioscler Thromb Vasc Biol. 2025;45(11):2086-2096. doi:10.1161/ATVBAHA.125.322574.
9.
Tamagawa-MineokaRKatohNKishimotoS. Platelet activation in patients with psoriasis: increased plasma levels of platelet-derived microparticles and soluble P-selectin. J Am Acad Dermatol. 2010;62(4):621-626. doi:10.1016/j.jaad.2009.06.053.
10.
FathyAN. Evaluation of soluble P-selectin and leptin serum levels in sera of patients of psoriasis and their possible role in the increase in the cardiovascular risks in psoriatic patients. J Clin Exp Dermatol Res. 2014;05(01):201. doi:10.4172/2155-9554.1000201
11.
SalehHMAAttiaEASOnsyAMSaadAAAbd EllahMMM. Platelet activation: a link between psoriasis per se and subclinical atherosclerosis – a case–control study. Br J Dermatol. 2013;169(1):68-75. doi:10.1111/bjd.12285.
12.
DavìGPatronoC. Platelet activation and atherothrombosis. N Engl J Med. 2007;357(24):2482-2494. doi:10.1056/NEJMra071014.
13.
GarshickMSTawilMBarrettTJ, et al.Activated platelets induce endothelial cell inflammatory response in psoriasis via COX-1. Arterioscler Thromb Vasc Biol. 2020;40(5):1340-1351. doi:10.1161/ATVBAHA.119.314008.
14.
GarshickMSBarrettTJWechterT, et al.Inflammasome signaling and impaired vascular health in psoriasis. Arterioscler Thromb Vasc Biol. 2019;39(4):787-798. doi:10.1161/ATVBAHA.118.312246.
15.
HersterFKarbachSChatterjeeMWeberANR. Platelets: underestimated regulators of autoinflammation in psoriasis. J Invest Dermatol. 2021;141(6):1395-1403. doi:10.1016/j.jid.2020.12.025.
16.
FanZWangLJiangHLinYWangZ. Platelet dysfunction and its role in the pathogenesis of psoriasis. Dermatology. 2020;237(1):56-65. doi:10.1159/000505536.
17.
MichelsonADBarnardMRKruegerLAValeriCRFurmanMI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin. Circulation. 2001;104(13):1533-1537. doi:10.1161/hc3801.095588.
18.
YokoyamaSIkedaHHaramakiNYasukawaHMuroharaTImaizumiT. Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates. JACC (J Am Coll Cardiol). 2005;45(8):1280-1286. doi:10.1016/j.jacc.2004.12.071.
19.
FinsterbuschMSchrottmaierWCKral-PointnerJBSalzmannMAssingerA. Measuring and interpreting platelet-leukocyte aggregates. Platelets. 2018;29(7):677-685. doi:10.1080/09537104.2018.1430358.
20.
Sanz-MartínezMTMogaESánchez MartínezMA, et al.High levels of platelet-lymphocyte complexes in patients with psoriasis are associated with a better response to anti–TNF-α therapy. J Invest Dermatol. 2020;140(6):1176-1183. doi:10.1016/j.jid.2019.08.457.
21.
Davizon-CastilloPRowleyJWRondinaMT. Megakaryocyte and platelet transcriptomics for discoveries in human health and disease. Arterioscler Thromb Vasc Biol. 2020;40(6):1432-1440. doi:10.1161/ATVBAHA.119.313280.
22.
StroberBRyanCVan De KerkhofP, et al.Recategorization of psoriasis severity: Delphi consensus from the international psoriasis council. J Am Acad Dermatol. 2020;82(1):117-122. doi:10.1016/j.jaad.2019.08.026.
23.
ArnettDKBlumenthalRSAlbertMA, et al.2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation. 2019;140(11):e596-e646. doi:10.1161/CIR.0000000000000678.
24.
AllenNBarrettTJGuoY, et al.Circulating monocyte-platelet aggregates are a robust marker of platelet activity in cardiovascular disease. Atherosclerosis. 2019;282:11-18. doi:10.1016/J.ATHEROSCLEROSIS.2018.12.029.
25.
BornGVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194(4832):927-929. doi:10.1038/194927b0.
26.
DannRHadiTMontenontE, et al.Platelet-derived MRP-14 induces monocyte activation in patients with symptomatic peripheral artery disease. JACC (J Am Coll Cardiol). 2018;71(1):53-65. doi:10.1016/j.jacc.2017.10.072.
EwelsPMagnussonMLundinSKällerM. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32(19):3047-3048. doi:10.1093/bioinformatics/btw354.
29.
DobinADavisCASchlesingerF, et al.STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15-21. doi:10.1093/bioinformatics/bts635.
30.
LiaoYSmythGKShiW. Featurecounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923-930. doi:10.1093/bioinformatics/btt656.
31.
LoveMIHuberWAndersS. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8.
WickhamH. Ggplot2: Elegant Graphics for Data Analysis. Springer; 2009. doi:10.1007/978-0-387-98141-3.
34.
SubramanianATamayoPMoothaVK, et al.Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545-15550. doi:10.1073/pnas.0506580102.
35.
KorotkevichGSukhovVBudinNShpakBArtyomovMNSergushichevA. Fast gene set enrichment analysis. bioRxiv. 2021;1:060012. Preprint posted online February. doi:10.1101/060012.
36.
NagasawaAMatsunoKTamuraSHayasakaKShimizuCMoriyamaT. The basis examination of leukocyte–platelet aggregates with CD45 gating as a novel platelet activation marker. Int J Lab Hematol. 2013;35(5):534-541. doi:10.1111/ijlh.12051.
37.
PeshkovaADSaliakhutdinovaSMSounbuliK, et al.The differential formation and composition of leukocyte-platelet aggregates induced by various cellular stimulants. Thromb Res. 2024;241:109092. doi:10.1016/j.thromres.2024.109092.
HersterFBittnerZCodreaMC, et al.Platelets aggregate with neutrophils and promote skin pathology in psoriasis. Front Immunol. 2019;10:1867. doi:10.3389/fimmu.2019.01867.
40.
TeagueHLVargheseNJTsoiLC, et al.Neutrophil subsets, platelets, and vascular disease in psoriasis. JACC, Basic Transl Sci. 2019;4(1):1-14. doi:10.1016/j.jacbts.2018.10.008.
41.
BergerMMaquaHLysajaK, et al.Platelets from patients with chronic inflammation have a phenotype of chronic IL-1β release. Res Pract Thromb Haemost. 2024;8(1):102261. doi:10.1016/j.rpth.2023.102261.
42.
ZamoraCCantóENietoJC, et al.Binding of platelets to lymphocytes: a potential anti-inflammatory therapy in Rheumatoid arthritis. J Immunol. 2017;198(8):3099-3108. doi:10.4049/jimmunol.1601708.
43.
ZamoraCCantóENietoJC, et al.Functional consequences of platelet binding to T lymphocytes in inflammation. J Leukoc Biol. 2013;94(3):521-529. doi:10.1189/jlb.0213074.
44.
StarossomSCVeremeykoTYungAWY, et al.Platelets play differential role during the initiation and progression of autoimmune neuroinflammation. Circ Res. 2015;117(9):779-792. doi:10.1161/CIRCRESAHA.115.306847.
45.
DinklaSVan CranenbroekBVan Der HeijdenWA, et al.Platelet microparticles inhibit IL-17 production by regulatory T cells through P-selectin. Blood. 2016;127(16):1976-1986. doi:10.1182/blood-2015-04-640300.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
